vs
德康医疗（DXCM）与赫兹（HTZ）财务数据对比。点击上方公司名可切换其他公司
赫兹的季度营收约是德康医疗的1.6倍（$2.0B vs $1.3B），德康医疗净利率更高（21.2% vs -16.6%，领先37.8%），德康医疗同比增速更快（21.6% vs 11.0%），过去两年德康医疗的营收复合增速更高（12.0% vs -7.7%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
赫兹全球控股是美国知名汽车租赁企业，总部位于佛罗里达州埃斯特罗。公司运营赫兹同名核心品牌，同时拥有Dollar、Firefly、Thrifty等多个汽车租赁子品牌，业务覆盖全球广泛市场，为客户提供多元出行租赁解决方案。
DXCM vs HTZ — 直观对比
营收规模更大
HTZ
是对方的1.6倍
$1.3B
营收增速更快
DXCM
高出10.6%
11.0%
净利率更高
DXCM
高出37.8%
-16.6%
两年增速更快
DXCM
近两年复合增速
-7.7%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $2.0B |
| 净利润 | $267.3M | $-333.0M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | — |
| 净利率 | 21.2% | -16.6% |
| 营收同比 | 21.6% | 11.0% |
| 净利润同比 | 153.6% | 24.8% |
| 每股收益（稀释后） | $0.67 | $-1.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMHTZ
| Q1 26 | $1.3B | $2.0B | ||
| Q4 25 | $1.3B | $2.0B | ||
| Q3 25 | $1.2B | $2.5B | ||
| Q2 25 | $1.2B | $2.2B | ||
| Q1 25 | $1.0B | $1.8B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $994.2M | $2.6B | ||
| Q2 24 | $1.0B | $2.4B |
净利润DXCMHTZ
| Q1 26 | $267.3M | $-333.0M | ||
| Q4 25 | $267.3M | $-194.0M | ||
| Q3 25 | $283.8M | $184.0M | ||
| Q2 25 | $179.8M | $-294.0M | ||
| Q1 25 | $105.4M | $-443.0M | ||
| Q4 24 | $151.7M | $-479.0M | ||
| Q3 24 | $134.6M | $-1.3B | ||
| Q2 24 | $143.5M | $-865.0M |
毛利率DXCMHTZ
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMHTZ
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | -11.0% | ||
| Q3 25 | 20.1% | 9.4% | ||
| Q2 25 | 18.4% | -14.5% | ||
| Q1 25 | 12.9% | -29.0% | ||
| Q4 24 | 17.0% | -27.6% | ||
| Q3 24 | 15.3% | -62.9% | ||
| Q2 24 | 15.7% | -20.1% |
净利率DXCMHTZ
| Q1 26 | 21.2% | -16.6% | ||
| Q4 25 | 21.2% | -9.6% | ||
| Q3 25 | 23.5% | 7.4% | ||
| Q2 25 | 15.5% | -13.5% | ||
| Q1 25 | 10.2% | -24.4% | ||
| Q4 24 | 13.6% | -23.5% | ||
| Q3 24 | 13.5% | -51.7% | ||
| Q2 24 | 14.3% | -36.8% |
每股收益（稀释后）DXCMHTZ
| Q1 26 | $0.67 | $-1.06 | ||
| Q4 25 | $0.67 | $-0.46 | ||
| Q3 25 | $0.70 | $0.42 | ||
| Q2 25 | $0.45 | $-0.95 | ||
| Q1 25 | $0.27 | $-1.44 | ||
| Q4 24 | $0.37 | $-1.57 | ||
| Q3 24 | $0.34 | $-4.34 | ||
| Q2 24 | $0.35 | $-2.82 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $583.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | — |
| 总资产 | $6.3B | $23.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMHTZ
| Q1 26 | $917.7M | $583.0M | ||
| Q4 25 | $917.7M | $565.0M | ||
| Q3 25 | $1.8B | $1.1B | ||
| Q2 25 | $1.2B | $503.0M | ||
| Q1 25 | $904.9M | $626.0M | ||
| Q4 24 | $606.1M | $592.0M | ||
| Q3 24 | $621.2M | $501.0M | ||
| Q2 24 | $939.2M | $568.0M |
股东权益DXCMHTZ
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $-459.0M | ||
| Q3 25 | $2.7B | $-317.0M | ||
| Q2 25 | $2.6B | $-504.0M | ||
| Q1 25 | $2.3B | $-262.0M | ||
| Q4 24 | $2.1B | $153.0M | ||
| Q3 24 | $2.0B | $681.0M | ||
| Q2 24 | $2.4B | $2.0B |
总资产DXCMHTZ
| Q1 26 | $6.3B | $23.3B | ||
| Q4 25 | $6.3B | $22.3B | ||
| Q3 25 | $7.5B | $23.0B | ||
| Q2 25 | $7.3B | $23.1B | ||
| Q1 25 | $6.8B | $22.0B | ||
| Q4 24 | $6.5B | $21.8B | ||
| Q3 24 | $6.4B | $23.0B | ||
| Q2 24 | $6.8B | $25.2B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
